{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:05:42Z","timestamp":1785153942387,"version":"3.55.0"},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"abstract":"<jats:p>ABSTRACT  Background:  The prognostic value of tumor-infiltrating lymphocytes has been studied in several cancers, but in gastric cancer, their evaluation by standard hematoxylin-eosin staining remains controversial.  Aims:  To analyze the prognostic value of tumor-infiltrating lymphocytes in gastric cancer and to investigate the association between tumor-infiltrating lymphocyte levels and a range of clinical and pathological factors in gastric cancer.  Results:  Forty-four patients were included with a mean age of 62 years, and 77% of the patients were classified as having pathological tumor stage 3 or pathological tumor stage 4. Lymph node metastases were noted in 66% of our patients. At diagnosis, 57% of patients were at an advanced stage (III). Patients with distant metastases were not included in this study. Evaluation of tumor-infiltrating lymphocytes in hematoxylin-eosin staining found that the mean tumor-infiltrating lymphocyte rate was 43 (extremes: 5-90%). 36% of patients had a tumor-infiltrating lymphocyte rate &gt;50%. The overall survival of our patients was 40 months. Patients with tumor-infiltrating lymphocytes &gt;50% had greater survival, without a significant correlation (p=0.275). A tumor-infiltrating lymphocyte rate =50% was correlated with age &gt;50 years (p=0.030), presence of lymph node involvement (p=0.023), and advanced tumor stage (III+IV) (p=0.05). In a multivariate analysis, the presence of lymph node involvement (p=0.045) and advanced tumor stage (III+IV) (p=0.015) were identified as independent factors associated with a low tumor-infiltrating lymphocyte rate =50%.  Conclusions:  Poor prognostic factors for gastric cancer (age &gt;50 years, presence of lymph node involvement, and advanced tumor stage) were associated with a low tumor-infiltrating lymphocyte rate assessed by hematoxylin-eosin staining. However, standardization of tumor-infiltrating lymphocyte assessment is essential to allow comparability between studies and integrate this parameter into routine practice.<\/jats:p>","DOI":"10.1590\/0102-672020260000019e1948","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:35:39Z","timestamp":1785152139000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of tumor-infiltrating lymphocytes and their association with clinical and pathological factors in gastric cancer"],"prefix":"10.1590","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8430-0072","authenticated-orcid":false,"given":"Dhouha","family":"BACHA","sequence":"first","affiliation":[{"name":"University of Tunis,  Tunisia; University of Tunis El Manar,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9269-8365","authenticated-orcid":false,"given":"Ines","family":"MALLEK","sequence":"additional","affiliation":[{"name":"University of Tunis,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1624-2923","authenticated-orcid":false,"given":"Mohamed","family":"HAJRI","sequence":"additional","affiliation":[{"name":"University of Tunis,  Tunisia; University of Tunis El Manar,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3841-2599","authenticated-orcid":false,"given":"Amani","family":"BENZARTI","sequence":"additional","affiliation":[{"name":"University of Tunis,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2955-9824","authenticated-orcid":false,"given":"Farah","family":"LOUED","sequence":"additional","affiliation":[{"name":"University of Tunis,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8897-398X","authenticated-orcid":false,"given":"Sana","family":"BEN-SLAMA","sequence":"additional","affiliation":[{"name":"University of Tunis,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3969-9751","authenticated-orcid":false,"given":"Lassad","family":"GHARBI","sequence":"additional","affiliation":[{"name":"University of Tunis,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5271-1054","authenticated-orcid":false,"given":"Ahlem","family":"LAHMAR","sequence":"additional","affiliation":[{"name":"University of Tunis,  Tunisia; Mongi Slim University Hospital,  Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1590\/0102-67202025000048e1917","article-title":"Tumor budding in gastric adenocarcinoma: prognostic value and association with clinicopathological markers","volume":"38","author":"Bacha D","year":"2025","journal-title":"Arq Bras Cir Dig"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/PAS.0000000000001409","article-title":"Assessment of tumor-infiltrating lymphocytes using international TILs working group (ITWG) system is a strong predictor of overall survival in colorectal carcinoma: a study of 1034 patients","volume":"44","author":"Fuchs TL","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the \u2018Immunoscore\u2019 in the classification of malignant tumours","volume":"232","author":"Galon J","year":"2014","journal-title":"J Pathol"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAP.0000000000000162","article-title":"Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology biomarkers working group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research","volume":"24","author":"Hendry S","year":"2017","journal-title":"Adv Anat Pathol"},{"issue":"37","key":"ref5","doi-asserted-by":"crossref","first-page":"62312","DOI":"10.18632\/oncotarget.17602","article-title":"Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis","volume":"8","author":"Jiang W","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ajcp\/aqy069","article-title":"Tumor-infiltrating lymphocytes in breast cancer: evaluating interobserver variability, heterogeneity, and fidelity of scoring core biopsies","volume":"150","author":"Khoury T","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification","volume":"64","author":"Lauren P","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.annonc.2020.01.011","article-title":"Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)","volume":"31","author":"Lee H","year":"2020","journal-title":"Ann Oncol"},{"issue":"32","key":"ref9","article-title":"Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a systematic review and meta-analysis","volume":"97","author":"Lee JS","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2217\/pgs-2019-0102","article-title":"High levels of tumor-infiltrating lymphocytes showed better clinical outcomes in FOLFOX-treated gastric cancer patients","volume":"21","author":"Li W","year":"2020","journal-title":"Pharmacogenomics"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle A","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal ID","year":"2020","journal-title":"Histopathology"},{"issue":"10135","key":"ref13","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s F","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gassur.2023.12.002","article-title":"Prognostic implications of tumor-infiltrating lymphocytes within the tumor microenvironment in gastric cancer","volume":"28","author":"Pereira MA","year":"2024","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s12094-022-03040-1","article-title":"Prognostic role and clinical significance of tumor-infiltrating lymphocyte (TIL) and programmed death ligand 1 (PD-L1) expression in gastric cancer: a systematic review and meta-analysis","volume":"25","author":"Ren J","year":"2023","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.18632\/oncotarget.12739","article-title":"The concept of immune surveillance against tumors. The first theories","volume":"8","author":"Ribatti D","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.annonc.2022.07.1942","article-title":"Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]","volume":"33","author":"Saberzadeh-Ardestani B","year":"2022","journal-title":"Ann Oncol"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado R","year":"2015","journal-title":"Ann Oncol"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","article-title":"Clinical relevance of host immunity in breast cancer: from TILs to the clinic","volume":"13","author":"Savas P","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"25","key":"ref20","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa2004413","article-title":"Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer","volume":"382","author":"Shitara K","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"ref21","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044163","article-title":"Prognostic role of tumour-infiltrating lymphocytes assessed by H&E-stained section in gastric cancer: a systematic review and meta-analysis","volume":"11","author":"Tian C","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/0284186X.2017.1403040","article-title":"Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists","volume":"57","author":"Tramm T","year":"2018","journal-title":"Acta Oncol"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.dld.2018.04.025","article-title":"Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)","volume":"50","author":"Zaanan A","year":"2018","journal-title":"Dig Liver Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2019.00071","article-title":"Scoring system for tumor-infiltrating lymphocytes and its prognostic value for gastric cancer","volume":"10","author":"Zhang D","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang L","year":"2003","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2018.05.024","article-title":"Tumor-infiltrating lymphocyte volume is a better predictor of neoadjuvant therapy response and overall survival in triple-negative invasive breast cancer","volume":"80","author":"Zhang L","year":"2018","journal-title":"Hum Pathol"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.5114\/aoms.2019.86101","article-title":"Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis and experimental validation","volume":"16","author":"Zhang N","year":"2019","journal-title":"Arch Med Sci"},{"issue":"34","key":"ref29","doi-asserted-by":"crossref","first-page":"57386","DOI":"10.18632\/oncotarget.18065","article-title":"Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis","volume":"8","author":"Zheng X","year":"2017","journal-title":"Oncotarget"}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":["Valor progn\u00f3stico dos linf\u00f3citos infiltrantes tumorais (lits)e sua associa\u00e7\u00e3o com fatores cl\u00ednicos e patol\u00f3gicos no c\u00e2ncer g\u00e1strico"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-67202026000100609&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:35:44Z","timestamp":1785152144000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202026000100609&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":29,"alternative-id":["S0102-67202026000100609"],"URL":"https:\/\/doi.org\/10.1590\/0102-672020260000019e1948","relation":{},"ISSN":["2317-6326","0102-6720"],"issn-type":[{"value":"2317-6326","type":"electronic"},{"value":"0102-6720","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e1948"}}